Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERTUGLIFLOZIN PIDOLATE Cause Drug ineffective? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Drug ineffective have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 3.1% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.

21
Reports of Drug ineffective with ERTUGLIFLOZIN PIDOLATE
3.1%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Drug ineffective From ERTUGLIFLOZIN PIDOLATE?

Of the 21 reports, 2 (9.5%) required hospitalization.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?

Fungal infection (58) Product dose omission issue (57) Nausea (55) No adverse event (53) Urinary tract infection (52) Diabetic ketoacidosis (34) Dizziness (33) Vomiting (31) Blood glucose increased (30) Product dose omission (27)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Drug ineffective Risk?

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI

Related Pages

ERTUGLIFLOZIN PIDOLATE Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective ERTUGLIFLOZIN PIDOLATE Demographics